Drug Development Institute

DDI Team

The DDI is led by a team of highly experienced scientists.

The Drug Development Institute is led by a team of highly experienced research and drug development scientists with:

  • Diversified industrial experience along the drug development value chain
  • Proven track records of delivering novel compounds and technologies for clinical development
  • Experience in managing projects using data-driven, milestone-based project management

For more information, contact the DDI team members individually or at ddi@osumc.edu.

Our Team

Jeffrey Patrick, PharmD

Jeffrey Patrick, PharmD

Senior Institute Director and Clinical Pharmacist

Email: jeffrey.patrick@osumc.edu

I am a residency-trained clinical pharmacist with nearly 20 years of pharmaceutical industry experience. I bring expertise in executive leadership, scientific and medical strategy and program building.

Janel Ezzell, PhD

Janel Ezzell, PhD

Director of Business and Portfolio Development

Email: Janel.Ezzell@osumc.edu

I am a business development professional with over seven years of experience negotiating agreements between academia and corporate partners.

Chad Bennett, PhD

Chad Bennett, PhD

Senior Director of Chemistry

Email: chad.bennett@osumc.edu | Phone: 614-685-9230

I am a process and medicinal chemist with over 12 years of experience in the pharmaceutical industry at Merck and Schering-Plough, working in both the discovery and early-development phases.

Gerard Hilinski, PhD

Gerard Hilinski, PhD

Senior Director of Biochemistry

Email: gerard.hilinski@osumc.edu

I am a biochemist with over 15 years of experience in design and synthesis of conformationally stabilized peptides. Previously at FogPharma as scientific co-founder, I bring distinctive expertise and perspective to the DDI.

Damien Gerald, PhD

Damien Gerald, PhD

Senior Director of Cancer Biology

Email: Damien.Gerald@osumc.edu

I am a cancer biologist supporting an oncology portfolio of small molecules and biologics. Previously at Eli Lilly and Company, I bring extensive expertise in leadership of preclinical programs as well as experience with molecular, cell-based and in vivo methods. 

Sebastian Biglione, PhD, PharmD, CCRP

Sebastian Biglione, PhD, PharmD, CCRP

Director of Clinical and Regulatory Strategy

Email: Sebastian.Biglione@osumc.edu

I am a residency-trained research pharmacist with six years of experience supporting all phases of clinical trials and biomedical IRB participation.

Celeste Alverez, PhD

Celeste Alverez, PhD

Technical Project Manager

Email: Celeste.Alverez@osumc.edu 

I am a project manager and medicinal chemist with nearly 10 years of experience in the design and synthesis of small molecule inhibitors for drug discovery, particularly relating to the field of oncology.

 

Reena Shakya, PhD

Reena Shakya, PhD

Cancer Biologist

Email: reena.shakya@osumc.edu | Phone: 614-293-1675

I am Ohio State’s director of the Target Validation Shared Resource (TVSR). I bring extensive experience with cancer xenografts, GEM models and in vivo validation.

Christopher Coss, PhD

Christopher Coss, PhD

Preclinical Pharmacologist

Email: christopher.coss@osumc.edu | Phone: 614-688-1309

I am an assistant professor in the Ohio State College of Pharmacy. Previously at GTx Inc., my experience ranges from preclinical models to late-stage clinical assays.

Cindy Evans

Cindy Evans

Administrative Assistant

Email: ddi@osumc.edu

I have over 20 years of experience in administrative management in a variety of roles from small business to academia.

Related Podcasts